Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.
Biomarker and diagnostic research for leukopenia has been reported in the published literature.
5 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2, 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06788691](https://clinicaltrials.gov/study/NCT06788691) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:35 PM UTC
Luspatercept for Clonal Cytopenias of Uncertain Significance
PHASE2 |
Weill Medical College of Cornell University |
RECRUITING |
[NCT06262542](https://clinicaltrials.gov/study/NCT06262542) | Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia | NA | Taichung Armed Forces General Hospital | UNKNOWN |
[NCT06360952](https://clinicaltrials.gov/study/NCT06360952) | A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC | — | Tasso Inc. | UNKNOWN |
[NCT00967785](https://clinicaltrials.gov/study/NCT00967785) | A Phase I Study of Mozobil in the Treatment of Patients With WHIMS | PHASE1 | National Institute of Allergy and Infectious Diseases (NIAID) | UNKNOWN |
[NCT07108023](https://clinicaltrials.gov/study/NCT07108023) | Hematological Disorders in EHPVO Patients | — | Rahab Nady | UNKNOWN |
296 publications have been identified in PubMed for leukopenia. Kisho has analyzed 197 by research type. Research spans Review / Meta-Analysis (27%), Case Report / Case Series (19%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 53 | 27% |
Patient case studies | 38 | 19% |
Clinical study results | 33 | 17% |
Laboratory research | 27 | 14% |
Disease patterns and progression | 27 | 14% |
Testing and diagnosis research | 12 | 6% |
New treatment approaches | 4 | 2% |
Other research | 3 | 2% |
Sheikh GT (2026). [PMID: 41530551](https://pubmed.ncbi.nlm.nih.gov/41530551/). *Eur J Nucl Med Mol Imaging*. [Review / Meta-Analysis]
Hanai S (2026). [PMID: 40962533](https://pubmed.ncbi.nlm.nih.gov/40962533/). *Immunol Med*. [Case Report / Case Series]
Kebede SS (2026). [PMID: 41960798](https://pubmed.ncbi.nlm.nih.gov/41960798/). *Biomed Res Int*. [Clinical Trial Publication]
Liang Q (2026). [PMID: 41630330](https://pubmed.ncbi.nlm.nih.gov/41630330/). *Medicine (Baltimore)*. [Case Report / Case Series]
Goh M (2026). [PMID: 41664754](https://pubmed.ncbi.nlm.nih.gov/41664754/). *Cureus*. [Case Report / Case Series]
Pendyala M (2026). [PMID: 41668818](https://pubmed.ncbi.nlm.nih.gov/41668818/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Baktybayeva L (2026). [PMID: 41898271](https://pubmed.ncbi.nlm.nih.gov/41898271/). *Biomedicines*. [Review / Meta-Analysis]
Chatrizeh M (2026). [PMID: 41955508](https://pubmed.ncbi.nlm.nih.gov/41955508/). *JCI Insight*. [Clinical Trial Publication]
Galán JE (2026). [PMID: 42041253](https://pubmed.ncbi.nlm.nih.gov/42041253/). *Microbiol Mol Biol Rev*. [Review / Meta-Analysis]
Sofianidi AA (2026). [PMID: 41726150](https://pubmed.ncbi.nlm.nih.gov/41726150/). *Oncol Rev*. [Review / Meta-Analysis]